Home » EMA Grants Orphan Drug Status to NovaBiotics Lynovex
EMA Grants Orphan Drug Status to NovaBiotics Lynovex
UK-based biotechnology company, NovaBiotics’ Lynovex has been granted orphan drug designation in Europe by the Committee on Orphan EMA.
Pharmaceutical Business Review
Pharmaceutical Business Review
Upcoming Events
-
07May
-
14May
-
30May